Poster Abstract Session:
242. HIV Renal and Bones
Saturday, October 29, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Tracks: Trainee, HIV-STD-TB, Adult ID

Renal and bone outcomes among HIV-infected patients exposed to EFV/TDF/FTC compared to other TDF-containing antiretroviral regimens: Findings from the Veterans Health Administration (VHA)
Joanne Lafleur, PharmD, MSPH ; Adam Bress, PharmD, MS ; Jacob Crook, MStat ; Stephen Esker, PharmD ; Heather Nyman, PharmD ; Thomas Reese, PharmD ; Roger Bedimo, MD ; Pablo Tebas, MD, FIDSA ; Lisa Rosenblatt, MD, MPH
Outcomes of tenofovir discontinuation among human immunodeficiency virus (HIV)-infected patients with suspected tenofovir-associated nephrotoxicity
Dustin Carr, PharmD ; James Johnson, PharmD ; Aimee Wilkin, MD, MPH ; Haley Gibbs, PharmD, MPH ; John Williamson, PharmD
Veterans Aging Cohort Study Index as a Marker of Bone Disease in HIV-Infected Patients
Lokesh Shahani, MD, MPH ; Katharine Breaux, PA-C, MPAS ; Maria Rodriguez-Barradas, MD, FIDSA
Risk Factors Associated with Avascular Necrosis in HIV-Infected Patients in the New Antiretroviral Therapy Era
Marcus Sandling, MD ; Nida Arif, MD ; Sara Taherkani, MD ; Ed Gracely, PhD ; Nader Toossi, MD ; Norman Johanson, MD ; Kimberly Dike, BS ; Zsofia Szep, MD
  • AVNposterfinal 10-24-16.pdf (129.0 kB)
  • Higher HIV Viral Load is Associated with Lower Levels of Vitamin D in Treatment-Naive HIV Patients.
    María Elena Ceballos, MD ; Paula Fernandez, RN ; Camila Carvajal, RN ; Angélica Dominguez, MSc ; Gilberto González, MD
  • ID week poster.pdf (1.7 MB)
  • Bone Mineral Density (BMD) Reductions after Tenofovir Disoproxil Fumarate (TDF) Initiation Are Not Associated with Changes in Phosphaturia: A Secondary Analysis of ACTG A5224s
    Samir Gupta, MD, MS ; Eunice Yeh, BSPH ; Douglas Kitch, MS ; Todd Brown, MD, PhD ; Charles Venuto, PhD ; Gene Morse, PharmD ; Belinda Ha, PhD ; Kathy Melbourne, PharmD, AAHIVP ; Grace Mccomsey, MD, FIDSA
  • IDWeek 2016 Poster 2188.pdf (1.2 MB)
  • CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.